12 Sep 2018 09:51
JPMORGAN EUROPEAN INVESTMENT TRUST PLC (the 'Company') | |
Legal Entity Identifier: 549300D8SPJFHBDGXS57 | |
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 August 2018 | |
Growth Portfolio * | |
Nestle | 5.1% |
Novartis | 4.0% |
JPMorgan European Smaller Companies Trust | 3.7% |
Roche Holdings | 3.6% |
Allianz | 2.7% |
Novo Nordisk | 1.8% |
Sanofi-Aventis | 1.8% |
UPM-Kymmene | 1.8% |
JPMorgan Europe Dynamic Small Cap A | 1.7% |
Repsol | 1.7% |
Total | 27.9% |
Income Portfolio * | |
Novartis | 3.0% |
Roche Holdings | 2.9% |
Total | 2.7% |
Allianz | 1.8% |
Sanofi-Aventis | 1.7% |
Unilever | 1.6% |
Novo Nordisk | 1.5% |
BASF | 1.5% |
Daimler | 1.2% |
Deutsche Telekom | 1.1% |
Total | 19.0% |
* Based on invested portfolio | |
Name of contact and telephone number for queries: | |
Debbie Sarfas 0044 207 742 3449 | |
Name of authorised company official responsible for making this notification: | |
Paul Winship 0044 207 742 9815 - Company Secretary | |
Date: 12 September 2018 | |